Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Psychedelic use is associated with major life changes across 10 domains

16

Apr 2026

Psychedelic use is associated with major life changes across 10 domains

Researchers created a new questionnaire to measure major life changes linked to psychedelic use and found that most surveyed adults reporting naturalistic psychedelic use said psychedelics had influenced at least one major change in their lives. These changes most often involved goals, values, and spirituality, were usually rated positively, and were more commonly reported by people with more frequent use.

Why AI is becoming a powerful tool in cancer drug discovery

16

Apr 2026

Why AI is becoming a powerful tool in cancer drug discovery

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important proof-of-feasibility reference point. It argues that precision oncology could benefit from AI-driven integration of multi-omics, federated learning, and adaptive trial design, but only if validation, fairness, interpretability, and regulatory alignment improve.

Study finds popular AI chatbots often give problematic health advice

16

Apr 2026

Study finds popular AI chatbots often give problematic health advice

Researchers audited five popular public-facing AI chatbots across 250 health prompts and found that 49.6% of responses were problematic, with especially weak performance on open-ended questions and in nutrition and athletic performance. The study also found poor citation quality, difficult readability, and very few refusals to answer, raising concerns about the reliability of chatbots for everyday health information.

How the immune system may influence Alzheimer’s, Parkinson’s, and related diseases

16

Apr 2026

How the immune system may influence Alzheimer’s, Parkinson’s, and related diseases

This review argues that neurodegeneration is shaped not only by toxic protein buildup but also by immune signaling, with microglia and T cells able to either protect the brain or worsen damage depending on context. It also highlights aging, head injury, and viral infection as major forces that reshape CNS immunity and may influence disease progression and future treatment strategies.

Researchers prove magnetic seizures are comparable to ECT in clinical response

16

Apr 2026

Researchers prove magnetic seizures are comparable to ECT in clinical response

A landmark international clinical trial led by researchers at the Centre for Addiction and Mental Health (CAMH) and University of California San Diego School of Medicine, published in The Lancet Psychiatry, has found that magnetic seizure therapy (MST) is as effective as electroconvulsive therapy (ECT)-the current gold-standard treatment for severe, treatment-resistant depression-with significantly fewer cognitive side effects. The study is the first large-scale, randomized clinical trial to directly compare MST with ECT, marking an important step toward a new treatment option for patients.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.